These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 17142805)
1. Localization of TGF-beta signaling intermediates Smad2, 3, 4, and 7 in developing and mature human and mouse kidney. Banas MC; Parks WT; Hudkins KL; Banas B; Holdren M; Iyoda M; Wietecha TA; Kowalewska J; Liu G; Alpers CE J Histochem Cytochem; 2007 Mar; 55(3):275-85. PubMed ID: 17142805 [TBL] [Abstract][Full Text] [Related]
2. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells. Leivonen SK; Ala-Aho R; Koli K; Grénman R; Peltonen J; Kähäri VM Oncogene; 2006 Apr; 25(18):2588-600. PubMed ID: 16407850 [TBL] [Abstract][Full Text] [Related]
3. Human eosinophils have an intact Smad signaling pathway leading to a major transforming growth factor-beta target gene expression. Kanzaki M; Shibagaki N; Hatsushika K; Mitsui H; Inozume T; Okamoto A; Dobashi Y; Ogawa H; Shimada S; Nakao A Int Arch Allergy Immunol; 2007; 142(4):309-17. PubMed ID: 17135762 [TBL] [Abstract][Full Text] [Related]
4. Smad expression in human atherosclerotic lesions: evidence for impaired TGF-beta/Smad signaling in smooth muscle cells of fibrofatty lesions. Kalinina N; Agrotis A; Antropova Y; Ilyinskaya O; Smirnov V; Tararak E; Bobik A Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1391-6. PubMed ID: 15166010 [TBL] [Abstract][Full Text] [Related]
5. Ultraviolet A1 phototherapy decreases inhibitory SMAD7 gene expression in localized scleroderma. Kreuter A; Hyun J; Skrygan M; Sommer A; Tomi NS; Breuckmann F; Altmeyer P; Gambichler T Arch Dermatol Res; 2006 Nov; 298(6):265-72. PubMed ID: 17009056 [TBL] [Abstract][Full Text] [Related]
6. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4. Kretschmer A; Moepert K; Dames S; Sternberger M; Kaufmann J; Klippel A Oncogene; 2003 Oct; 22(43):6748-63. PubMed ID: 14555988 [TBL] [Abstract][Full Text] [Related]
7. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats]. Miao Y; Zhang W; Zhong M; Ma X; Qi TG; Sun H Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):366-70. PubMed ID: 17456374 [TBL] [Abstract][Full Text] [Related]
8. All-trans retinoic acid inhibited chondrogenesis of mouse embryonic palate mesenchymal cells by down-regulation of TGF-beta/Smad signaling. Yu Z; Xing Y Biochem Biophys Res Commun; 2006 Feb; 340(3):929-34. PubMed ID: 16410076 [TBL] [Abstract][Full Text] [Related]
9. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer. Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654 [TBL] [Abstract][Full Text] [Related]
11. Smad protein mediated transforming growth factor beta1 induction of apoptosis in the MDPC-23 odontoblast-like cell line. He WX; Niu ZY; Zhao SL; Smith AJ Arch Oral Biol; 2005 Nov; 50(11):929-36. PubMed ID: 16183370 [TBL] [Abstract][Full Text] [Related]
12. Cloning of Smad2, Smad3, Smad4, and Smad7 from the goldfish pituitary and evidence for their involvement in activin regulation of goldfish FSHbeta promoter activity. Lau MT; Ge W Gen Comp Endocrinol; 2005 Mar; 141(1):22-38. PubMed ID: 15707600 [TBL] [Abstract][Full Text] [Related]
13. Balance of profibrotic and antifibrotic [corrected] signaling in nephrogenic systemic fibrosis skin lesions. Schieren G; Gambichler T; Skrygan M; Burkert B; Altmeyer P; Rump LC; Kreuter A Am J Kidney Dis; 2010 Jun; 55(6):1040-9. PubMed ID: 20430497 [TBL] [Abstract][Full Text] [Related]
14. Smad signal and TGFbeta induced apoptosis in human lymphoma cells. Sebestyén A; Barna G; Nagy K; Jánosi J; Paku S; Kohut E; Berczi L; Mihalik R; Kopper L Cytokine; 2005 Jun; 30(5):228-35. PubMed ID: 15927846 [TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells. Matsuo SE; Leoni SG; Colquhoun A; Kimura ET J Endocrinol; 2006 Jul; 190(1):141-50. PubMed ID: 16837618 [TBL] [Abstract][Full Text] [Related]
16. Expression of Smad protein by normal skin fibroblasts and hypertrophic scar fibroblasts in response to transforming growth factor beta1. Xie JL; Qi SH; Pan S; Xu YB; Li TZ; Liu XS; Liu P Dermatol Surg; 2008 Sep; 34(9):1216-24; discussion 1224-5. PubMed ID: 18616749 [TBL] [Abstract][Full Text] [Related]
17. Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta. Park YN; Chae KJ; Oh BK; Choi J; Choi KS; Park C Hepatogastroenterology; 2004; 51(56):396-400. PubMed ID: 15086168 [TBL] [Abstract][Full Text] [Related]
18. Cooperation between GATA4 and TGF-beta signaling regulates intestinal epithelial gene expression. Belaguli NS; Zhang M; Rigi M; Aftab M; Berger DH Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1520-33. PubMed ID: 17290010 [TBL] [Abstract][Full Text] [Related]
19. Smad expression during kidney development. Vrljicak P; Myburgh D; Ryan AK; van Rooijen MA; Mummery CL; Gupta IR Am J Physiol Renal Physiol; 2004 Apr; 286(4):F625-33. PubMed ID: 14656760 [TBL] [Abstract][Full Text] [Related]
20. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling. Brown KA; Pietenpol JA; Moses HL J Cell Biochem; 2007 May; 101(1):9-33. PubMed ID: 17340614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]